PetMed Express, Inc. (NASDAQ:PETS) Short Interest Update

PetMed Express, Inc. (NASDAQ:PETS) saw a significant decrease in short interest in the month of March. As of March 13th, there was short interest totaling 774,341 shares, a decrease of 27.2% from the February 26th total of 1,064,222 shares. Currently, 3.7% of the company’s stock are short sold. Based on an average daily trading volume, of 104,949 shares, the short-interest ratio is currently 7.4 days.

PetMed Express Price Performance

Shares of NASDAQ:PETS opened at $2.23 on Friday. The business’s 50-day moving average is $2.84 and its 200 day moving average is $2.72. PetMed Express has a 1 year low of $1.57 and a 1 year high of $4.32. The firm has a market capitalization of $47.72 million, a P/E ratio of -0.71 and a beta of 0.72.

PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Thursday, February 5th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.44). PetMed Express had a negative return on equity of 70.81% and a negative net margin of 35.51%.The business had revenue of $40.66 million during the quarter, compared to analyst estimates of $54.04 million. On average, analysts expect that PetMed Express will post 0.19 EPS for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of PetMed Express in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Sell” and a consensus target price of $3.20.

Institutional Trading of PetMed Express

A number of institutional investors have recently bought and sold shares of PETS. Empowered Funds LLC increased its stake in PetMed Express by 14.2% during the 4th quarter. Empowered Funds LLC now owns 68,651 shares of the company’s stock valued at $220,000 after purchasing an additional 8,535 shares in the last quarter. Man Group plc lifted its stake in shares of PetMed Express by 10.7% during the fourth quarter. Man Group plc now owns 167,152 shares of the company’s stock worth $535,000 after buying an additional 16,113 shares during the period. Bridgeway Capital Management LLC lifted its stake in shares of PetMed Express by 17.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 126,351 shares of the company’s stock worth $404,000 after buying an additional 18,535 shares during the period. Jain Global LLC purchased a new stake in shares of PetMed Express during the fourth quarter valued at $78,000. Finally, Steel Partners Holdings L.P. purchased a new stake in shares of PetMed Express during the fourth quarter valued at $620,000. 73.33% of the stock is currently owned by institutional investors and hedge funds.

About PetMed Express

PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.

Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.